TMPRSS2 and prostate cancer: Tomlins and colleagues (2005) identified recurrent gene fusions of TMPRSS2 to two ETS transcription factors, ERG and ETV1, and found evidence to suggest that these fusions may occur in the majority of prostate cancer cases [2].